These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
603 related articles for article (PubMed ID: 8971390)
1. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation. de la Rubia J; Sanz GF; Martín G; Sempere A; Picón I; Carral A; Larrea L; Martínez J; Soler MA; Bonanad S; López F; Jarque I; Sanz MA Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390 [TBL] [Abstract][Full Text] [Related]
2. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells. Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929 [TBL] [Abstract][Full Text] [Related]
3. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study. Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254 [TBL] [Abstract][Full Text] [Related]
4. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)]. Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349 [TBL] [Abstract][Full Text] [Related]
5. BAVC regimen and autograft for acute myelogenous leukemia in second complete remission. Meloni G; Vignetti M; Avvisati G; Capria S; Micozzi A; Giona F; Mandelli F Bone Marrow Transplant; 1996 Oct; 18(4):693-8. PubMed ID: 8899182 [TBL] [Abstract][Full Text] [Related]
6. Single-institution results of autologous bone marrow transplantation in acute myeloid leukemia. Lambertenghi Deliliers G; Annaloro C; Della Volpe A; Oriani A; Mozzana R; Pozzoli E; Tagliaferri E; Soligo D Haematologica; 1995; 80(2):136-41. PubMed ID: 7628752 [TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650 [TBL] [Abstract][Full Text] [Related]
8. Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation. Fernández-Jiménez MC; Canales MA; Ojeda E; de Bustos JG; Aguado MJ; Hernández-Navarro F Haematologica; 1999 Nov; 84(11):1007-11. PubMed ID: 10553161 [TBL] [Abstract][Full Text] [Related]
9. [Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients]. Tomás JF; Gómez-García de Soria V; Pinilla I; Lamana M; Figuera A; Arranz R; Cámara R; Fernández-Villalta MJ; Alegre A; Fernández-Rañada JM Med Clin (Barc); 1997 Feb; 108(6):201-6. PubMed ID: 9102484 [TBL] [Abstract][Full Text] [Related]
10. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol. Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387 [TBL] [Abstract][Full Text] [Related]
11. Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission. Jerjis S; Roovers E; Muus P; Schaap N; de Witte T Bone Marrow Transplant; 1998 Jul; 22(1):13-9. PubMed ID: 9678790 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165 [TBL] [Abstract][Full Text] [Related]
13. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [TBL] [Abstract][Full Text] [Related]
14. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574 [TBL] [Abstract][Full Text] [Related]
15. Autologous blood stem cell transplantation for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplantation does not prolong disease-free survival. de la Rubia J; Sanz GF; Martín G; Martínez J; Cervera J; Solves P; Jiménez C; Arnao M; Vicente A; Jarque I; Sempere A; Sanz MA Haematologica; 1999 Feb; 84(2):125-32. PubMed ID: 10091410 [TBL] [Abstract][Full Text] [Related]
16. Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia. Kang HJ; Shin HY; Choi HS; Han KS; Ahn HS Bone Marrow Transplant; 2004 Mar; 33(5):471-6. PubMed ID: 14716339 [TBL] [Abstract][Full Text] [Related]
17. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia. Bassan R; Raimondi R; Lerede T; D'emilio A; Buelli M; Borleri G; Personeni A; Bellavita P; Rodeghiero F; Barbui T Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868 [TBL] [Abstract][Full Text] [Related]
18. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma. Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281 [TBL] [Abstract][Full Text] [Related]
19. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission. Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004 [TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]